Full Press Release Details
| Dr. Reddy's Laboratories Ltd. | |
| 8-2-337, Road No. 3, Banjara Hills, | |
| Hyderabad - 500 034, Telangana, | |
| India. | |
| CIN: L85195TG1984PLC004507 | |
| Tel :+91 40 4900 2900 | |
| Fax :+91 40 4900 2999 | |
| Email :mail@drreddys.com | |
| www.drreddys.com |
| Corporate Relationship Department | National Stock Exchange of India Ltd. | |||
| BSE Limited | "Exchange Plaza" | |||
| Dalal Street, Fort | Bandra-Kurla Complex, Bandra (East), | |||
| Mumbai - 400 001 | Mumbai - 400 051 | |||
| Fax Nos.: | 022-22723121 / 22723719 / | Fax Nos.: | 022-26598120/ 26598237/ | |
| 22722037 / 22722039 | 26598238 | |||
| Scrip Code: 500124 | Scrip Code: DRREDDY-EQ |
Further to our intimation dated January 28,
2019 with regard to the audit of our API manufacturing plant at Miryalaguda (Nalgonda District), we would like to inform you that
we have received the Establishment Inspection Report (EIR) from US FDA, for the above-referred facility, indicating closure of
the audit and the inspection classification of this facility is determined as Voluntary Action Initiated (VAI).
This is for your information.
| /s/ Sandeep Poddar | |
| Sandeep Poddar | |
| Company Secretary |
CC:- New York Stock Exchange Inc.(Stock Code :RDY)